Corcept Therapeutics (CORT) Stock Forecast
Corcept Therapeutics
AI forecast: CORT
The AI publishes a target price for the next trading day, the end of the week and the end of the month. The change is measured from the latest price. These are statistical estimates, not investment advice.
Price over the last 6 months
CORT: score, valuation and dividends
AI-Stock Invest describes the company by published rules: its Smart Score against peers, valuation against the sector, dividend history checked across sources, and red flags. The same for every reader — information, not a forecast and not advice.
Open in AI-Stock Invest → CORT valuation vs sectorPremium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Forecast track record
The forecast track record — every past forecast next to the actual close — is part of Premium.
Unlock PremiumAbout This Company
Corcept Therapeutics Inc. is a pharmaceutical company engaged in the development of drugs for the treatment of serious metabolic and psychiatric disorders. The company’s main product modifies the action of cortisol, also known as the “stress hormone,” by blocking cortisol’s binding to one of two known receptors—the type 2 glucocorticoid receptor.
